Profile | GDS5420 / 219236_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 785.83 | 75 |
GSM1296119 | B_lesional_pre-dose | 212.82 | 53 |
GSM1296076 | C_lesional_pre-dose | 271.67 | 59 |
GSM1296092 | D_lesional_pre-dose | 401.61 | 65 |
GSM1296103 | E_lesional_pre-dose | 414.69 | 64 |
GSM1296078 | F_lesional_pre-dose | 354.25 | 63 |
GSM1296107 | G_lesional_pre-dose | 230.48 | 54 |
GSM1296109 | H_lesional_pre-dose | 342.61 | 61 |
GSM1296080 | I_lesional_pre-dose | 1001.18 | 79 |
GSM1296090 | J_lesional_pre-dose | 290.77 | 59 |
GSM1296074 | K_lesional_pre-dose | 235.91 | 57 |
GSM1296111 | L_lesional_pre-dose | 195.04 | 51 |
GSM1296099 | M_lesional_pre-dose | 496.2 | 67 |
GSM1296086 | O_lesional_pre-dose | 444.24 | 66 |
GSM1296117 | P_lesional_pre-dose | 218.08 | 53 |
GSM1296113 | Q_lesional_pre-dose | 151.54 | 45 |
GSM1296096 | R_lesional_pre-dose | 429.88 | 65 |
GSM1296105 | S_lesional_pre-dose | 607.88 | 71 |
GSM1296098 | T_lesional_pre-dose | 1104.86 | 81 |
GSM1296101 | U_lesional_pre-dose | 568.78 | 70 |
GSM1296121 | V_lesional_pre-dose | 274.24 | 57 |
GSM1296088 | W_lesional_pre-dose | 562.29 | 70 |
GSM1296082 | X_lesional_pre-dose | 496.94 | 68 |
GSM1296115 | Y_lesional_pre-dose | 205.92 | 52 |
GSM1296084 | Z_lesional_pre-dose | 641.53 | 72 |
GSM1296072 | B_lesional_day8 | 246.3 | 55 |
GSM1296069 | L_lesional_day8 | 149.54 | 45 |
GSM1296071 | P_lesional_day8 | 330.64 | 59 |
GSM1296070 | Y_lesional_day8 | 363.67 | 62 |
GSM1296073 | V_lesional_day8 | 172.96 | 50 |
GSM1296034 | A_lesional_day15 | 1424.19 | 85 |
GSM1296041 | G_lesional_day15 | 343.87 | 61 |
GSM1296035 | R_lesional_day15 | 350.16 | 61 |
GSM1296038 | U_lesional_day15 | 384.29 | 63 |
GSM1296047 | B_lesional_day15 | 194.98 | 51 |
GSM1296039 | E_lesional_day15 | 218.82 | 54 |
GSM1296042 | H_lesional_day15 | 280.34 | 57 |
GSM1296043 | L_lesional_day15 | 247.43 | 54 |
GSM1296037 | M_lesional_day15 | 355.03 | 61 |
GSM1296046 | P_lesional_day15 | 303.91 | 58 |
GSM1296044 | Q_lesional_day15 | 111.08 | 40 |
GSM1296045 | Y_lesional_day15 | 198.64 | 50 |
GSM1296025 | C_lesional_day15 | 753.19 | 74 |
GSM1296033 | D_lesional_day15 | 714.03 | 73 |
GSM1296027 | I_lesional_day15 | 505.52 | 68 |
GSM1296032 | J_lesional_day15 | 486.69 | 67 |
GSM1296024 | K_lesional_day15 | 883.9 | 77 |
GSM1296031 | W_lesional_day15 | 504.52 | 67 |
GSM1296028 | X_lesional_day15 | 647.04 | 72 |
GSM1296029 | Z_lesional_day15 | 717.95 | 73 |
GSM1296026 | F_lesional_day15 | 413.75 | 65 |
GSM1296030 | O_lesional_day15 | 637.39 | 72 |
GSM1296040 | S_lesional_day15 | 867.52 | 77 |
GSM1296036 | T_lesional_day15 | 709.04 | 73 |
GSM1296048 | V_lesional_day15 | 279.09 | 58 |
GSM1296059 | A_lesional_day43 | 437.28 | 65 |
GSM1296066 | G_lesional_day43 | 263 | 56 |
GSM1296060 | R_lesional_day43 | 449.88 | 66 |
GSM1296063 | U_lesional_day43 | 254.88 | 56 |
GSM1296064 | E_lesional_day43 | 273.43 | 58 |
GSM1296067 | H_lesional_day43 | 341.46 | 60 |
GSM1296062 | M_lesional_day43 | 989.28 | 79 |
GSM1296068 | Q_lesional_day43 | 104.24 | 38 |
GSM1296050 | C_lesional_day43 | 337.45 | 62 |
GSM1296057 | D_lesional_day43 | 454.16 | 66 |
GSM1296052 | I_lesional_day43 | 407.4 | 65 |
GSM1296054 | J_lesional_day43 | 624.81 | 71 |
GSM1296049 | K_lesional_day43 | 687.46 | 73 |
GSM1296055 | W_lesional_day43 | 205.7 | 52 |
GSM1296053 | X_lesional_day43 | 898.41 | 77 |
GSM1296058 | Z_lesional_day43 | 316.34 | 60 |
GSM1296051 | F_lesional_day43 | 294.37 | 60 |
GSM1296056 | O_lesional_day43 | 440.19 | 66 |
GSM1296065 | S_lesional_day43 | 407.61 | 64 |
GSM1296061 | T_lesional_day43 | 1033 | 80 |
GSM1296095 | A_non-lesional_pre-dose | 325.28 | 61 |
GSM1296120 | B_non-lesional_pre-dose | 178.05 | 49 |
GSM1296077 | C_non-lesional_pre-dose | 465.71 | 67 |
GSM1296093 | D_non-lesional_pre-dose | 789.52 | 75 |
GSM1296104 | E_non-lesional_pre-dose | 246.03 | 56 |
GSM1296079 | F_non-lesional_pre-dose | 677.25 | 73 |
GSM1296108 | G_non-lesional_pre-dose | 205.69 | 52 |
GSM1296110 | H_non-lesional_pre-dose | 210.28 | 51 |
GSM1296081 | I_non-lesional_pre-dose | 902.14 | 77 |
GSM1296091 | J_non-lesional_pre-dose | 313.47 | 60 |
GSM1296075 | K_non-lesional_pre-dose | 226.81 | 56 |
GSM1296112 | L_non-lesional_pre-dose | 238.24 | 53 |
GSM1296100 | M_non-lesional_pre-dose | 843.85 | 76 |
GSM1296087 | O_non-lesional_pre-dose | 423.48 | 66 |
GSM1296118 | P_non-lesional_pre-dose | 377.02 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 138.53 | 44 |
GSM1296097 | R_non-lesional_pre-dose | 380.24 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 324.99 | 60 |
GSM1296102 | U_non-lesional_pre-dose | 476.57 | 66 |
GSM1296122 | V_non-lesional_pre-dose | 314.45 | 59 |
GSM1296089 | W_non-lesional_pre-dose | 285.43 | 58 |
GSM1296083 | X_non-lesional_pre-dose | 804.68 | 75 |
GSM1296116 | Y_non-lesional_pre-dose | 218.68 | 52 |
GSM1296085 | Z_non-lesional_pre-dose | 510.38 | 68 |